Edesa Biotech is trading 6.1% higher at $4.09 on October 5, 2026, with no confirmed catalyst identified.

  • Supplied price context shows a rebound from the October 2 close of $3.86.
  • No company announcement dated October 5 was found; its news page lists August 19, 2026, and August 13, 2026, as its latest releases. The provided broader market indicators are mixed and do not establish a market-wide explanation.